TopoⅡ及Ki67在基底细胞样乳腺癌中的相关作用进展(3)
[12]Andreopoulou E，Sparano JA. Seeing red：anthracyclines for breast cancer[J]. Oncology(Williston Park)，2011，25(2)：128，131，134.
[13]Al-Trawneh SA，El-Abadelah MM，Zahra JA，et al. Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents[J]. Bioorg Med Chem，2011，19(8)：2541-2548.
[14]Zaczek A，Markiewicz A，Jaskiewicz J，et al. Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples[J]. Clin Biochem，2010，43(10-11)：891-898.
, http://www.100md.com
[15]Vranic S，Frkovic-Grazio S，Lamovec J，et al. Adenoid cystic carcinomas of the breast have low Topo Ⅱ alpha expression but frequently overexpress EGFR protein without EGFR gene amplification[J]. Hum Pathol，2010，41(11)：1617-1623.
[16]Stamatakos GS，Kolokotroni EA，Dionysiou DD，et al. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy：Mimicking a clinical study[J]. J Theor Biol，2010，266(1)：124-139.
, 百拇医药
[17]Sheen-Chen SM，Huang CY，Zhang H，et al. Lack of prognostic value of topoisomerase Ⅱ alpha in patients with breast cancer：analysis with tissue microarray[J]. Anticancer Res，2010，30(6)：2459-2462.
[18]Schindlbeck C，Mayr D，Olivier C，et al. Topoisomerase Ⅱalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer[J]. J Cancer Res Clin Oncol，2010，136(7)：1029-1037.
, 百拇医药
[19]Parissenti AM，Chapman JA，Kahn HJ，et al. Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients[J]. Breast Cancer Res Treat，2010，119(2)：347-356.
[20]Nielsen KV，Muller S，Moller S，et al. Aberrations of ERBB2 and TOP2A genes in breast cancer[J]. Mol Oncol，2010，4(2)：161-168.
[21]Mukherjee A，Shehata M，Moseley P，et al. Topo 2 alpha protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer[J]. Br J Cancer，2010，103(12)：1794-1800.
, http://www.100md.com
[22]Moelans CB，De Weger RA，Van Blokland MT，et al. Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer[J]. Mod Pathol，2010，23(1)：62-70.
[23]Mays AN，Osheroff N，Xiao Y，et al. Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15；17)therapy-related acute promyelocytic leukemia[J]. Blood，2010，115(2)：326-330.
[24]Loss LA，Sadanandam A，Durinck S，et al. Prediction of epigenetically regulated genes in breast cancer cell lines[J]. BMC Bioinformatics，2010，11：305.
, 百拇医药
[25]Konecny GE，Pauletti G，Untch M，et al. Association between HER2，TOP2A，and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer[J]. Breast Cancer Res Treat，2010，120(2)：481-489.
[26]Tanei T，Shimomura A，Shimazu K，et al. Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer[J]. Eur J Surg Oncol，2011，37(2)：155-161., http://www.100md.com(黄雅娟 于晓红 杜峰)
[13]Al-Trawneh SA，El-Abadelah MM，Zahra JA，et al. Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents[J]. Bioorg Med Chem，2011，19(8)：2541-2548.
[14]Zaczek A，Markiewicz A，Jaskiewicz J，et al. Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples[J]. Clin Biochem，2010，43(10-11)：891-898.
, http://www.100md.com
[15]Vranic S，Frkovic-Grazio S，Lamovec J，et al. Adenoid cystic carcinomas of the breast have low Topo Ⅱ alpha expression but frequently overexpress EGFR protein without EGFR gene amplification[J]. Hum Pathol，2010，41(11)：1617-1623.
[16]Stamatakos GS，Kolokotroni EA，Dionysiou DD，et al. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy：Mimicking a clinical study[J]. J Theor Biol，2010，266(1)：124-139.
, 百拇医药
[17]Sheen-Chen SM，Huang CY，Zhang H，et al. Lack of prognostic value of topoisomerase Ⅱ alpha in patients with breast cancer：analysis with tissue microarray[J]. Anticancer Res，2010，30(6)：2459-2462.
[18]Schindlbeck C，Mayr D，Olivier C，et al. Topoisomerase Ⅱalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer[J]. J Cancer Res Clin Oncol，2010，136(7)：1029-1037.
, 百拇医药
[19]Parissenti AM，Chapman JA，Kahn HJ，et al. Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients[J]. Breast Cancer Res Treat，2010，119(2)：347-356.
[20]Nielsen KV，Muller S，Moller S，et al. Aberrations of ERBB2 and TOP2A genes in breast cancer[J]. Mol Oncol，2010，4(2)：161-168.
[21]Mukherjee A，Shehata M，Moseley P，et al. Topo 2 alpha protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer[J]. Br J Cancer，2010，103(12)：1794-1800.
, http://www.100md.com
[22]Moelans CB，De Weger RA，Van Blokland MT，et al. Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer[J]. Mod Pathol，2010，23(1)：62-70.
[23]Mays AN，Osheroff N，Xiao Y，et al. Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15；17)therapy-related acute promyelocytic leukemia[J]. Blood，2010，115(2)：326-330.
[24]Loss LA，Sadanandam A，Durinck S，et al. Prediction of epigenetically regulated genes in breast cancer cell lines[J]. BMC Bioinformatics，2010，11：305.
, 百拇医药
[25]Konecny GE，Pauletti G，Untch M，et al. Association between HER2，TOP2A，and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer[J]. Breast Cancer Res Treat，2010，120(2)：481-489.
[26]Tanei T，Shimomura A，Shimazu K，et al. Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer[J]. Eur J Surg Oncol，2011，37(2)：155-161., http://www.100md.com(黄雅娟 于晓红 杜峰)